Dietary interventions in cancer

Clinical and Translational Oncology

Volumn 6, Issue 8, 2004, Pages 496-500

  Cobo, Susana Casado ^a   Colomer, Ramon ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951207906     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/BF02713089     Document Type: Article

References (31)

1. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69:491-7. (Pubitemid 10018703)
2. Laviano A, Rossi-Fanelli F. Pathogenesis of cancer anorexia. Still doubts after all these years? Nutrition 2003; 19:67-8. (Pubitemid 36044491)
3. Knox LS, Crosby LO, Feurer ID, Buzby GP, Miller CL, Mullen JL. Energy expenditure in malnourished cancer patients. Ann Surg 1983;197(2):152-62. (Pubitemid 13184440)
4. Heber D, Byerley LO, Tchekmedyian NS. Hormonal and metabolic abnormalities in the malnourished cancer patient: effects on host-tumor interaction. JPEN J Parenter Enteral Nutr 1992;16(6 Suppl):60S-4S. Review.
5. Fearon KC, Falconer JS, Slater C, McMillan DC, Ross JA, Preston T. Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. Ann Surg 1998; 227(2):249-54. (Pubitemid 28087919)
6. Body JJ. The syndrome of anorexia-cachexia. Curr Opin Oncol 1999;11(4):255-60. (Pubitemid 29312744)
7. Fearon KC, Barber MD, Moses AG. The cancer cachexia syndrome. Surg Oncol Clin N Am 2001;10(1):109-26. (Pubitemid 32102189)
8. Sutton LM, Demark-Wahnefried W, Clipp EC. Management of terminal cancer in elderly patients. Lancet Oncol 2003;4:149-57. (Pubitemid 36322305)
9. De Cáceres Zurita ML, Ruiz Mata F, Seguí Palmer MA. Recetas de cocina y de autoayuda para el enfermo oncológico. 2nd ed. Madrid: Mayo Ediciones, 2004.
10. Chace D, Keane M, Lung JA. What to eat if you have cancer. McGraw-Hill/Contemporary Books, 1996.
11. Heller AR, Fischer S, Rossel T, et al. Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. Br J Nutr 2002;87 Suppl 1:S95-101.
12. Takagi K, Yamamori H, Furukawa K, Miyazaki M, Tashiro T. Perioperative supplementation of EPA reduces immunosuppression induced by postoperative chemoradiation therapy in patients with esophageal cancer. Nutrition 2001;17(6):478-9. (Pubitemid 32499544)
13. Heller AR, Rossel T, Gottschlich B, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004;111(4):611-6. (Pubitemid 39045330)
14. Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003;52(10):1479-86. (Pubitemid 37176729)
15. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1998;82(2):395-402. (Pubitemid 28060258)
16. Jatoi A, Rowland K, Loprinzi CL, et al. North Central Cancer Treatment Group. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 2004; 22(12):2469-76. (Pubitemid 41115406)
17. Menéndez JA, del Mar Barbacid M, Montero S, et al. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 2001;37(3):402-13. (Pubitemid 32182331)
18. Menéndez JA, Ropero S, del Barbacid MM, et al. Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells. Breast Cancer Res Treat 2002;72(3):203-19. (Pubitemid 34430002)
19. Menéndez JA, Ropero S, Lupu R, Colomer R. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n- 6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expression. Oncol Rep 2004; 11(6):1241-52.
20. Menéndez JA, Colomer R, Lupu R. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) is a selective estrogen-response modulator in human breast cancer cells: gamma-linolenic acid antagonizes estrogen receptor-dependent transcriptional activity, transcriptionally represses estrogen receptor expression and synergistically enhances tamoxifen and ICI 182,780 (Faslodex) efficacy in human breast cancer cells. Int J Cancer 2004;109(6):949-54. (Pubitemid 38528697)
21. DeGraffenried LA, Friedrichs WE, Fulcher L, et al. Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann Oncol 2003; 14(7):1051-6. (Pubitemid 36950169)
22. Menéndez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Int J Oncol 2004;24(3):591-608.
23. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. Cancer J Clin 2002; 52:72-91. (Pubitemid 34256834)
24. Laviano A, Meguid M, Rossi-Fanelli F. Cancer anorexia: clinical implications, pathogenesis and therapeutic strategies. Lancet Oncol 2003;4:686-94. (Pubitemid 37407436)
25. Maltoni M, Nanni O, Scarpi E , Rossi D, Serra P, Amadori D. High dose progestins for the treatment of cancer anorexia-cachexia: a systematic review of randomised clinical trials. Ann Oncol 2001;12:289-300. (Pubitemid 32288683)
26. Jatoi A, Yamashita J, Sloan JA , Novotny PJ, Windschitl HE, Loprinzi CL. Does megestrol acetate down regulate interleukine-6 in patients with cancer cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group Investigation. Support Care Cancer 2002; 10:71-5. (Pubitemid 36055888)
27. Klein TW, Lane B, Newton CA, Friedman H. The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 2000;225:1-8.
28. Moses AWG, Slater C, Preston T, Barber MD, Fearon KC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 2004; 90:996-1002. (Pubitemid 38495818)
29. Tsuzuki T, Igarashi M, Miyazawa T. Conjugated eicosapentaenoic acid (EPA) inhibits transplanted tumor growth via membrane lipid peroxidation in nude mice. J Nutr 2004;134(5):1162-6. (Pubitemid 38619957)
30. Yuri T, Danbara N, Tsujita-Kyutoku M, et al. Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea- induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. Nutr Cancer 2003; 45(2):211-7. (Pubitemid 37022795)
31. Solanas M, Hurtado A, Costa I, et al. Effects of a high olive oil diet on the clinical behavior and histopathological features of rat DMBA-induced mammary tumors compared with a high corn oil diet. Int J Oncol 2002;21(4):745-53.